Theragen
PrivateLast Round
VC Round
Jun 21, 2017
Company Overview
Theragen operates in Healthcare & Life Sciences and is based in Jacksonville, Florida. Its latest recorded funding round was a VC Round in June 2017.
Theragen is a therapeutic devices company that develops and manufactures non-invasive, electrical stimulation products that deliver therapeutic energy for healing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement, Healthcare Analytics, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theragen Comparables
Compare Theragen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enovis Corp | 81% | |
| Zimmer Biomet | 77% | |
| Orthofix Medical Inc. | 76% |
For institutional investors. Book with your work email.
Theragen Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Theragen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ballast Point Ventures | VC Round |
| RC Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 65% MoM, reaching 5.8K.
- Jan 25, 2026
Monthly visitors grew 50% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 23, 2026
ActaStim presents new data identifying predictors of patient outcomes following use of ActaStim(R)-S Bone Growth Stimulator at SMISS 2026 Annual Forum in Florida on Sep 23rd '26.
For institutional investors. Book with your work email.
Theragen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Theragen's valuation, stock price, and market status.
Is Theragen a public or private company?
Theragen is a private company.
What is the current stock price of Theragen?
Theragen is a private company, so its shares have no public market price. Caplight tracks Theragen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Theragen worth (valuation)?
Valuation information for Theragen is not publicly available.
Can I buy Theragen stock?
Theragen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Theragen's last funding round?
Theragen's most recent funding round was VC Round on June 21, 2017.
Who are the main investors in Theragen?
Key investors in Theragen include Ballast Point Ventures, RC Capital.
Will Theragen IPO soon?
No public IPO plans have been announced for Theragen.
How can I track Theragen secondary market activity?
Caplight tracks bids, offers, and trades in Theragen's shares on secondary markets.